Evidence map›Paper›PMID 25113086›Full record

ArticleJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2014

Over-the-counter and prescription sleep medication and incident stroke: the REasons for Geographic and Racial Differences in Stroke study.

Megan E Petrov, Virginia J Howard, Dawn Kleindorfer, Michael A Grandner, Jennifer R Molano, George Howard

Open access · greenAbstract read
In one paragraph

Article in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. A Closer Look at Yoga Nidra: Sleep Lab Protocol.International journal of yoga therapy · 2021
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. The associations of self-stigma, social constraints, and sleep among Chinese American breast cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Megan E PetrovCollege of Nursing & Health Innovation, Arizona State University, Phoenix, Arizona. Electronic address: Megan.Petrov@asu.edu.
Virginia J HowardDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama.
Dawn KleindorferDepartment of Neurology & Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Michael A GrandnerDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Jennifer R MolanoDepartment of Neurology & Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.
George HowardDepartment of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama.
University of Alabama at Birmingham · USUniversity of Cincinnati Medical Center · USArizona State University · USUniversity of Pennsylvania · US

Funding

VCID and Stroke in a Bi-racial National CohortU01NS041588 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CUSHMAN, MARY, HOWARD, GEORGE · 2002 to 2022
$96.0M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2013 to 2026
$19.5M
RESEARCH TRAINING COREP60MD000502 · NIMHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PARTRIDGE, EDWARD E. · 2003 to 2016
$16.2M
Understanding Cohort Effects on Stroke, VCID, and Cognition After Major Epidemiologic TransitionsR01NS041588 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MARY CUSHMAN, VIRGINIA J. HOWARD · 2001 to 2026
$8.8M
UAB Health Services Research (HSR) Training ProgramT32HS013852 · AHRQ · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEVITAN, EMILY B, MUGAVERO, MICHAEL J · 2003 to 2024
$8.0M
Cardiovascular and Metabolic Risk Factors Associated with Short Sleep DurationK23HL110216 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI GRANDNER, MICHAEL A · 2012 to 2016
$813k
Sleep and Health in the Social EnvironmentR21ES022931 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI GRANDNER, MICHAEL A · 2012 to 2013
$436k
AHRQ HHS 5 T32 HS013852-09AHRQ HHS HS013852AHRQ HHS HS013852-07AHRQ HHS T32 HS013852NHLBI NIH HHS K23 HL110216NHLBI NIH HHS K23HL110216NIDDK NIH HHS P30 DK079626NIEHS NIH HHS R21 ES022931NIEHS NIH HHS R21ES022931NIMHD NIH HHS 3 P60 MD000502-08S1NIMHD NIH HHS P60 MD000502NINDS NIH HHS R01 NS041588NINDS NIH HHS U01 NS041588
6 · The paper itself

Abstract

backgroundPreliminary evidence suggests sleep medications are associated with risk of vascular events; however, the long-term vascular consequences are understudied. This study investigated the relation between sleep medication use and incident stroke.

methodsWithin the REasons for Geographic And Racial Differences in Stroke study, 21,678 black participants and white participants (≥45 years) with no history of stroke were studied. Participants were recruited from 2003 to 2007. From 2008 to 2010, participants self reported their prescription and over-the-counter sleep medication use over the past month. Suspected stroke events were identified by telephone contact at 6-month intervals and associated medical records were retrieved and physician-adjudicated. Proportional hazards analysis was used to estimate hazard ratios for incident stroke associated with sleep medication use (0, 1-14, and 15+ days per month) controlling for sociodemographics, stroke risk factors, mental health symptoms, and sleep apnea risk.

resultsAt the sleep assessment, 9.6% of the sample used prescription sleep medication and 11.1% used over-the-counter sleep aids. Over an average follow-up of 3.3 ± 1.0 years, 297 stroke events occurred. Over-the-counter sleep medication use was associated with increased risk of incident stroke in a frequency-response relationship (P = .014), with a 46% increased risk for 1-14 days of use per month (hazards ratio [HR] = 1.46; 95% confidence interval [CI], .99-2.15) and a 65% increased risk for 15+ days (HR = 1.65; 95% CI, .96-2.85). There was no significant association with prescription sleep medications (P = .80).

conclusionsOver-the-counter sleep medication use may independently increase the risk of stroke beyond other risk factors in middle-aged to older individuals with no history of stroke.

Indexed as

AgedBlack PeopleDrug UtilizationFemaleFollow-Up StudiesHumansHypnotics and SedativesIncidenceMaleMiddle AgedNonprescription DrugsPredictive Value of TestsPrescription DrugsRisk AssessmentRisk FactorsSelf ReportHypnotics and SedativesNonprescription DrugsPrescription Drugsover-the-counterREGARDS Studysleeping pillsSleep medicationstroke

Identifiers

PMID25113086
PMCPMC4157947
OpenAlexW2033077496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.